Clinical Development Director, Immunology (Hybrid)

Merck; San Francisco (CA); Hybrid; USD 256,000 - 403,000; Full time

Benefits offered by this job

Annual bonus

Long‑term incentive

Comprehensive benefits

401(k)

Job summary

Merck in the United States is seeking a Clinical Director (Immunology) to lead late‑stage development across investigational compounds. The role oversees the full cycle from disease indication selection through trial design, execution, analysis, regulatory filing, and publication.

The position requires strong leadership of clinical scientists, cross‑functional collaboration with regulatory, statistics and manufacturing, and travel about 25% to manage trials globally.

Qualifications

• Minimum of 5 years of clinical and/or development experience (academia, clinical medicine, and/or corporate clinical development).
• Demonstrated record of scientific scholarship and achievement
• Prior experience in design and execution of phase 2 or 3 clinical trials in rheumatologic diseases is preferred
• Strong interpersonal skills, as well as the ability to work collaboratively in a cross-functional team environment

Responsibilities

• Author detailed development documents, presentations, budgets, and position papers for internal and external audiences
• Facilitate collaborations with external researchers around the world
• Travel on company business about twenty (20) percent of the time to manage future or ongoing clinical research projects.
• Monitor and manage the conduct of ongoing or new clinical trials for investigational drugs

Skills

Clinical Development

Clinical Research

Clinical Trial Planning

Cross-Functional Teamwork

Immunology

Rheumatology

Education

MD/DO

MD/PhD

Job description

Merck in the United States is seeking a Clinical Director (Immunology) to lead late‑stage development across investigational compounds. The role oversees the full cycle from disease indication selection through trial design, execution, analysis, regulatory filing, and publication.

The position requires strong leadership of clinical scientists, cross‑functional collaboration with regulatory, statistics and manufacturing, and travel about 25% to manage trials globally.